Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.8 USD | -1.58% | +2.33% | +6.98% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.98% | 14.39B | |
-1.79% | 104B | |
+3.21% | 97.47B | |
+5.18% | 22.25B | |
-13.79% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.45% | 16.36B | |
+40.73% | 12.37B | |
+302.58% | 8.43B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- UBS Adjusts Price Target on Neurocrine Biosciences to $128 From $135, Maintains Buy Rating